Research Director
Dr. Daniel Cameron - Page 2
Clinical Trial Expertise
Where |
Years |
Research Study |
|
| Glaxo |
1988 |
Lyme Disease |
| Ciba-Geigy |
1988 |
Hypertension |
| Eli Lilly |
1988 |
Hypertension |
| Squibb |
1988-1989 |
Acute Bronchitis |
| G.D. Searle |
1988-1989 |
Generalized Anxiety |
| Eli Lilly |
1988-1989 |
Analgesic (phase I, II) |
| Upjohn |
1989 |
Streptococcal Pharyngitis; Uncomplicated Urinary Tract Infection; Wound and Soft Tissue Infection |
| Lyme Disease Practice and Research |
1997-2000 |
Lyme Disease Surveillance Database |
| Pfizer |
2002-2003 |
Gemini study Clinical Utility
study for Cholesterol and Hypertension Phase IIIb Open-labeled,
multi-center trial |
| Columbia |
2001-present |
Subinvestigator NIH sponsered trial - Columbia |
| Lyme Disease Practice and Research |
1997-2001 |
Amoxicillin Clinical Trial |
| Merck |
2003 |
Migraine Therapy Evaluation Protocol
-Multi-centere, open-label, crossover study comparing Maxalt
with usual care oral migraine medication |
| Genzyme |
2004-present |
REACH Program An International
Prospective Observational Registry in Subjects at Risk Of Atherothrombotic
Events |
| Watson |
2004 |
MATRIX Trial Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin TDS |
|
|
|
Online Extras
